BioConnections
  • Home page
    • Coronavirus 2019-nCoV
    • Antibiotic Resistance
  • CHROMagar
  • MBlo IVDR
  • CoVID-19 products
  • Gonogen
  • MICROBIOLOGICS
  • MICRONAUT Broth Microdilution
  • Sifin Antisera
  • Newsletter 1
  • Newsletter 2
  • Mycology
  • BD Glucan key role
  • contact
  • CORIS BIOCONCEPT
  • Coris ReSCape
  • Coris RESIST
  • ontact Bench Reagents
  • Bench Reagents
  • MBLo Contact Neg Controls
Picture

​Lateral Flow Assays

FungiXpert Lateral Flow Assays
Our rapid tests utilise lateral flow assay to detect most common fungal pathogens including Aspergillus, Candida, and Cryptococcus, Results are qualitative but with the use of our 'Rapid Lateral Flow Reader' they can be recorded quantitatively.   These rapid test products significantly reduces turn-around-times  and opens the door to the benefits of combination testing in diagnosing fungal infections.

         LFAs available for Cryptococcus, Aspergillus (antigen & antibody) and Candida
Picture
FungiXpert  Cryptococcal Capsular Polysaccharide Detection Lateral Flow Assay
Overview
This product is used for the detection of cryptococcal capsular polysaccharide antigen in serum or CSF. This LFAt is mainly used in the clinical diagnosis of cryptococcal infection. Cryptococcal infection can occur in several parts of the body, most commonly in the central nervous system and lungs. An estimated mortality of cryptococcal infection was 625,000 persons annually.
High-Risk Patients
• HIV patients • ICU patients • Organ transplant recipients
• Cancer patients • Diabetes patients • Leukemia patients

Product Characteristics

Name
​Cryptococcal Capsular Polysaccharide Detection Lateral Flow Assay
Method
Lateral Flow Assay
Sample Type
Serum, CSF
Specification
25 Test/kit
Detection Time
10 minutes
Detection Target
Cryptococcus spp.
Stability
2 years at 2-30C
Low Detection Limit
0.5 ng/mL
Operation Method
Picture
Product Comparison
Product
FungiXpert
Immy
Detection Limit
0.5 ng/mL
1.0 ng/mL
FungiXpert  Aspergillus Galactomannan Detection Lateral Flow Assay

Overview
The incidence of Invasive Aspergillosis (IA) in immunosuppressed patients is rapidly increasing due to antibiotic abuse. Aspergillus fumigatus is one of the most common pathogens that cause severe aspergillus infection in patients with immunosuppressive disease, followed by aspergillus flavus, aspergillus niger and aspergillus terreus. Due to lack of typical clinical manifestations and effective early diagnosis methods, IA has a high mortality rate of 50% to 100%. Early rapid detection is a key factor in the effective treatment and reduction of death in IA. 

Product Characteristics
Name
Aspergillus Galactomannan Detection Lateral Flow Assay
Method
​Lateral Flow Assay
Sample Type
​Serum, BAL fluid
Specification
​25 tests/kit,
Detection Time
10 minutes
​Detection  Target 
Aspergillus spp.
​Stability
2 years at 2-30C
​Low Detection Limit
1ng/mL
Picture
FungiXpert  Aspergillus IgG Aspergillus IgM  Antibody Detection Lateral Flow Assays

Overview
These products uses colloidal gold immunochromatography technology to detect aspergillus-specific lgG  or lgM antibodies in human serum, providing a rapid and effective auxiliary aid for the diagnosis of susceptible populations. Chronic and allergic forms of pulmonary aspergillosis are estimated to affect over three million people worldwide. Antibody testing is central to diagnosis of these conditions. Furthermore, an antigen-antibody combined approach has been recommended. When combining the results of GM and Aspergillus-antibody, the sensitivity would be increased significantly. 

​Product Characteristics
​Name
Aspergillus lgG Antibody Detection Lateral Flow Assay  & Aspergillus lgM Antibody Detection Lateral Flow Assay 
​Method 
​Lateral Flow Assay 
​Sample type 
​Serum 
​Specification 
​25 tests/kit,
​Detection time
​10 min
Detection target
Aspergillus spp. 
​Stability 
2 years at 2-30C
Low detection limit
​5 AU/ml
Picture
FungiXpert  Candida Mannan Detection Lateral Flow Assay

​
Overview

With the wide application of antibiotics, immunosuppressants and corticosteroids in clinical practice, the incidence of deep fungal infection is increasing year by year. Deep fungal infection invades the organs and causes systemic infection. Mannan is a component of the cell wall of candida albicans and filamentous fungi. Systemic fungal infection lacks specific clinical symptoms and early rapid detection methods. Our product uses colloidal gold immunochromatography technology to detect mannan antigen in human serum, providing a rapid and effective auxiliary aid for the diagnosis of susceptible populations. ​

​​Product Characteristics
Name
Candida Mannan Detection Lateral Flow Assay
Method
​Lateral Flow Assay
Sample type
​Serum, BAL fluid 
Specification
25 tests/kit
Detection time
​10 min 
Detection target
Candida spp
Stability
 2 years at 2-30C
Low detection limit
​0.5 ng/ml
Picture

    How can we help you?

Submit
Picture
Brindley Court, Victoria Business Park
Knypersley ST8 7PP
T: 01782 516 010 
E: welcome@bioconnections.co.uk
  • Home page
    • Coronavirus 2019-nCoV
    • Antibiotic Resistance
  • CHROMagar
  • MBlo IVDR
  • CoVID-19 products
  • Gonogen
  • MICROBIOLOGICS
  • MICRONAUT Broth Microdilution
  • Sifin Antisera
  • Newsletter 1
  • Newsletter 2
  • Mycology
  • BD Glucan key role
  • contact
  • CORIS BIOCONCEPT
  • Coris ReSCape
  • Coris RESIST
  • ontact Bench Reagents
  • Bench Reagents
  • MBLo Contact Neg Controls